Sources | Names Used |
---|---|
GDSC1000, FIMM | Cytarabine |
CTRPv2 | cytarabine hydrochloride |
PharmacoGx | Cytarabine |
Database | Identifier |
---|---|
Smiles: | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl |
Inchikey: | KCURWTAZOZXKSJ-UHFFFAOYSA-N |
Pubchem: | 5351180 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DNTT | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-13 |
mRNA | ATAD5 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-18 |
mRNA | MED28 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-14 |
mRNA | LEF1 | GDSC1000 | pan-cancer | AAC | 0.27 | 4e-10 |
mRNA | CENPC | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-16 |
mRNA | DTL | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-19 |
mRNA | CPSF6 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-18 |
mRNA | HNRNPDL | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-18 |
mRNA | HMGB1 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-20 |
mRNA | HNRNPD | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-20 |